Live Webinar on generics and biosimilars in the treatment of Multiple Sclerosis

Karolina Kowalska
401

We are pleased to confirm that our live webinar on Nursing considerations on the use of generics and biosimilars in the treatment of Multiple Sclerosis will be taking place in November!

Date: Wednesday, 20 November 2024 at 12:30 pm CET 

 

          Register now:     Register for the Webinar

And join the speakers in an interactive discussion. The language will be English. 

This webinar focuses on the critical role of nurses in administering generics and biosimilars in the treatment of multiple sclerosis (MS). With the increasing availability of these cost-effective alternatives, it is essential for nursing professionals to understand the safety, efficacy, and patient management aspects of these therapies. We will explore practical strategies for educating patients, monitoring for potential side effects, and ensuring seamless transitions between therapies, drawing on the latest clinical insights and nursing best practices.

Meet the speakers

profile
Piet Eelen
RN, MSc, National MS Center,
Belgium


Piet Eelen is a Clinical Nurse Specialist Multiple Sclerosis working in the National Multiple Sclerosis Center (NMSC) of Melsbroek, Belgium. He has a post-bachelor degree in Rehabilitation and Continence Nursing. From 1990 until 2011 he worked as a head nurse of a rehabilitation ward. Since 2012 he works as a clinical nurse specialist guiding and supporting persons with MS in his clinical practice, with a special focus on chronic disease management and lifestyle factors in MS. He organizes courses for nurses to stimulate development and education, in the NMSC and in Belgium. He participates and collaborates with national and international healthcare associations. He is an invited speaker and member of advisory boards organized by pharma companies. Finally he participates and organizes research projects in MS in the NMSC. Since 2012 he is the president of the Belgian Association of MS-Nurses. Since 2020 he is the chair of the syllabus committee of MS Nurse PRO

profile
Amy Perrin Ross
APN, MSN, CNRN, MSCN,
Loyola University Medical Center (USA)


Amy Perrin Ross is the Neuroscience Program Coordinator at Loyola University Medical Center in Maywood, Illinois. She is the Coordinator of the MS Center at Loyola. 

Ms. Ross earned her undergraduate and graduate degrees from Loyola University in Chicago, Illinois. She has also completed coursework for her doctoral degree at the University of Illinois Medical Center. She is board certified as a Neuroscience Nurse by the American Board of Neuroscience Nursing, and as a Multiple Sclerosis Nurse by the Multiple Sclerosis Nursing International Certification Board.

Ms. Ross is an active participant in a variety of medical societies, including the American Association of Neuroscience Nurses, the American Association of Critical Care Nurses, the Multiple Sclerosis Society, the Multiple Sclerosis Association of America, and the International Organization of Multiple Sclerosis Nurses and the Consortium of MS Centers. She is a Clinical Reviewer for the International Journal of MS Care. Her work has been published in numerous journals, including Multiple Sclerosis, Frontiers in Neurology, the International Journal of MS Care, the International Journal of Clinical Practice, Neurology, Practical Neurology and the Journal of Neuroscience Nursing. Ms. Ross has participated in more than 40 research studies and has been invited to speak before numerous national and international meetings and conferences. She has been honored for her work in the field, receiving the 2015 June Halper Award of Excellence in International MS Nursing, recognizing her for leadership and creativity in the care of people with MS and their families.  

Contact us if you have any questions!

placeholder

The webinar is supported by SANDOZ, without any involvement in the elaboration of the scientific programme and presentations.

About our translations

All Blogposts, e-learning Courses, e-Newsletters, e-Newsflashes and the website content of MS Nurse PRO is originally created in English (UK). 
Our Educational Read Blogposts and our e-learning courses are reviewed by our scientific committee on accuracy and objectiveness. 
Next, the content is auto-translated by Microsoft Translator and made available on our platform. 
The translated content is not language reviewed with the exception of our e-learning Course content.
MS Nurse PRO has put a process in place to have our e-learning Courses language reviewed by native speaking experts (nurses or neurologists). 
We make all translated e-learning Courses available immediately and next, the language review process is started. This review process can take several months. 

Generics Biosimilar
© Copyright EMSP VZW